Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review

Date
2015-09-03
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract

Cholestyramine is a bile acid sequestrant that has been used in the treatment of hypercholesterolemia, pruritus due to elevated bile acid levels, and diarrhea due to bile acid malabsorption. This medication can rarely cause hyperchloremic nonanion gap metabolic acidosis, a complication featured in this report of an adult male with concomitant acute kidney injury. This case emphasizes the caution that must be taken in prescribing cholestyramine to patients who may also be volume depleted, in renal failure, or taking spironolactone.

Description
Keywords
Citation
Fareed B. Kamar and Rory F. McQuillan, “Hyperchloremic Metabolic Acidosis due to Cholestyramine: A Case Report and Literature Review,” Case Reports in Nephrology, vol. 2015, Article ID 309791, 3 pages, 2015. doi:10.1155/2015/309791